FGC
LKFT

Financial Gravity Companies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Financial Gravity Companies’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$233K Buy
+2,302
New +$233K 0.21% 102
2018
Q1 		$96K Buy
1,045
+165
+19% +$17.8K 0.1% 191
2017
Q4 		$104K Buy
+880
New +$83.2K 0.12% 170

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Financial Gravity Companies's LKFT Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2018: 2,302 shares worth $233K. The stake represents 0.21% of the portfolio and ranks #102 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in LKFT as recently as Q1 2018.

Financial Gravity Companies first reported a position in LKFT in Q4 2017 and has held it in 3 quarters since. 85 funds tracked by Wall St. Rank hold LKFT as of Q4 2018.

  • Financial Gravity Companies held 2,302 shares of Lakefront Biotherapeutics American Depositary Shares worth $233K as of Q4 2018.
  • Lakefront Biotherapeutics American Depositary Shares was a new Financial Gravity Companies position in Q4 2018.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.21% of Financial Gravity Companies's portfolio in Q4 2018, its #102 holding.
  • Financial Gravity Companies first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2017 and has held it in 3 quarters since.
  • 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.